✦ LIBER ✦

Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation

✍ Scribed by Alberto Sánchez-Fueyo; Antoni Rimola; Luis Grande; Josep Costa; Antoni Mas; Miguel Navasa; Isabel Cirera; Jose Maria Sánchez-Tapias; Juan Rodés

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 90 KB
Volume: 31
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.510310233

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B virus cellular immunity afte

Hepatitis B virus cellular immunity after liver transplantation: A role in preventing hepatitis B virus recurrence?

✍ Anne Marie Roque-Afonso 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

Chronic hepatitis B virus (HBV) infection is a common cause of advanced liver disease and hepatocellular carcinoma and has become a worldwide public health issue. Liver transplantation (LT) is the most effective therapeutic option for HBV-infected patients who have acute or chronic liver failure and

Hepatitis B immunoglobulin and/or nucleo

Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: A systematic review

✍ Evangelos Cholongitas; John Goulis; Evangelos Akriviadis; Geore V. Papatheodorid 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

A combination of hepatitis B immunoglobulin (HBIG) and nucleos(t)ide analogues (NUCs) is currently recommended as prophylaxis against the recurrence of hepatitis B virus (HBV) after liver transplantation (LT), but the optimal protocol is a matter of controversy. The aim of this study was the identif

Prophylaxis of hepatitis B virus recurre

Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants

✍ Alfredo Marzano; Pietro Lampertico; Vincenzo Mazzaferro; Silvia Carenzi; Mauro V 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

Fulminant hepatitis B virus: Recurrence

Fulminant hepatitis B virus: Recurrence after liver transplantation in two patients also infected with hepatitis delta virus

✍ W A Marsman; R H Wiesner; K P Batts; J J Poterucha; M K Porayko; H G Niesters; P 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

From the 1 Division of Liver Transplantation and the 2 Division of Pathology, Mayo Clinic lents/mL (geq/mL) as the lowest level of detection. 7

Factors associated with viral breakthrou

Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation

✍ Henry Lik-Yuen Chan; Albert Ka-Keung Chui; Wan-Yee Lau; Francis Ka-Leung Chan; M 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

This study aimed to investigate the factors associated with viral breakthrough among liver transplant recipients who receive lamivudine monoprophylaxis. Consecutive patients receiving liver transplantation for HBV-related liver disease from June 1999 to October 2000 were studied. All patients receiv

Mutational pattern of hepatitis B virus

Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under hbig immunoglobulin after liver transplantation

✍ Hans L. Tillmann; Christian Trautwein; Thomas Bock; Klaus H. Böker; Elmar Jäckel 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB 👁 1 views

## Famciclovir (FCV) and lamivudine (LAM) reduce viral replication in patients with recurrent hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT). Eighteen of 20 patients with insufficient response to FCV were treated with 100 mg LAM daily after OLT. These patients had s